AGN,Activist Ackman says Allergan CEO has conflict over letting goUPDATE 3-Ackman: Allergan CEO has conflict of interest on takeover offer (Adds Allergan board letter to Ackman, closing share prices)  UPDATE 3-Ackman: Allergan CEO has conflict of interest on takeover offer (Adds Allergan board letter to Ackman, closing share prices) May 19 Activist investor William Ackman said on Monday in a letter to takeover target Allergan Inc's  board of directors that the top executive has a "disabling" conflict of interest because accepting a takeover means losing the top job.UPDATE 3-Ackman: Allergan CEO has conflict of interest on takeover offer (Adds Allergan board letter to Ackman, closing share prices)  
GOOGL,Google said to be in talks to buy streaming-video site Twitch -WSJRPT-Google said to be in talks to buy streaming-video site Twitch -WSJBRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.    BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   (Repeats to additional subscribers with no change of text)BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.     RPT-Google said to be in talks to buy streaming-video site Twitch -WSJBRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.    BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   (Repeats to additional subscribers with no change of text)BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.    May 18 Google Inc was said to be in talks to acquire video-streaming service Twitch, according to a report in The Wall Street Journal on Sunday.RPT-Google said to be in talks to buy streaming-video site Twitch -WSJBRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.    BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   (Repeats to additional subscribers with no change of text)BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.     
GOOG,Google said to be in talks to buy streaming-video site Twitch -WSJRPT-Google said to be in talks to buy streaming-video site Twitch -WSJBRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.    BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   (Repeats to additional subscribers with no change of text)BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.     RPT-Google said to be in talks to buy streaming-video site Twitch -WSJBRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.    BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   (Repeats to additional subscribers with no change of text)BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.    May 18 Google Inc was said to be in talks to acquire video-streaming service Twitch, according to a report in The Wall Street Journal on Sunday.RPT-Google said to be in talks to buy streaming-video site Twitch -WSJBRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.    BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   (Repeats to additional subscribers with no change of text)BRIEF-Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.   Google acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  May 19 Google Inc :  * Mobile company divide announces acquisition by Google IncGoogle acquires mobile service company DivideGoogle acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.  Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job. SAN FRANCISCO, May 19 Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.Google acquires mobile service company Divide SAN FRANCISCO Google Inc said it has acquired Divide, a company whose software allows corporations to manage the personal smartphones that consumers increasingly use on the job.     
AIG,No liability for BofA for allegedly concealing $10 bln AIG case NEW YORK, May 19 A federal appeals court said Bank of America Corp was not liable to shareholders for allegedly concealing a $10 billion fraud lawsuit by American International Group Inc, whose filing led to a 20-percent one-day plunge in the bank's stock price. 
T,US STOCKS-Wall Street flat as growth concerns breed cautionEMERGING MARKETS-Bovespa hit by China data, ore prices; America Movil sinks IPCAT&T; makes bet on video with $48.5 billion DirecTV bidAT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; Inc plans to pay $48.5 billion to buy DirecTV, in the latest sign that the wireless industry and the U.S. television market are set to converge as customers consume more video on their mobile devices.AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)        AT&T; makes bet on video with $48.5 billion DirecTV bidAT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; Inc plans to pay $48.5 billion to buy DirecTV, in the latest sign that the wireless industry and the U.S. television market are set to converge as customers consume more video on their mobile devices.AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       By Asher Levine     SAO PAULO, May 19 Latin American stocks dropped on Monday as a decline in iron ore prices hammered shares of Brazilian miner Vale while America Movil drove losses in Mexico's bourse after AT&T; said it would sell its stake in the Mexican telecommunications firm.     The broader MSCI Latin American stock index  nearly erased the previous session's gains though most of the region's currencies strengthened slightly against the dollar.     Data from China on Sunday shoAT&T; makes bet on video with $48.5 billion DirecTV bidAT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; Inc plans to pay $48.5 billion to buy DirecTV, in the latest sign that the wireless industry and the U.S. television market are set to converge as customers consume more video on their mobile devices.AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)         EMERGING MARKETS-Bovespa hit by China data, ore prices; America Movil sinks IPCAT&T; makes bet on video with $48.5 billion DirecTV bidAT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; Inc plans to pay $48.5 billion to buy DirecTV, in the latest sign that the wireless industry and the U.S. television market are set to converge as customers consume more video on their mobile devices.AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)        AT&T; makes bet on video with $48.5 billion DirecTV bidAT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; Inc plans to pay $48.5 billion to buy DirecTV, in the latest sign that the wireless industry and the U.S. television market are set to converge as customers consume more video on their mobile devices.AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       By Asher Levine     SAO PAULO, May 19 Latin American stocks dropped on Monday as a decline in iron ore prices hammered shares of Brazilian miner Vale while America Movil drove losses in Mexico's bourse after AT&T; said it would sell its stake in the Mexican telecommunications firm.     The broader MSCI Latin American stock index  nearly erased the previous session's gains though most of the region's currencies strengthened slightly against the dollar.     Data from China on Sunday shoAT&T; makes bet on video with $48.5 billion DirecTV bidAT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; Inc plans to pay $48.5 billion to buy DirecTV, in the latest sign that the wireless industry and the U.S. television market are set to converge as customers consume more video on their mobile devices.AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)        * Indexes: Dow off 0.05 pct, S&P; up 0.11 pct, Nasdaq up 0.46 pct   (Updates to market open, adds quote)EMERGING MARKETS-Bovespa hit by China data, ore prices; America Movil sinks IPCAT&T; makes bet on video with $48.5 billion DirecTV bidAT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; Inc plans to pay $48.5 billion to buy DirecTV, in the latest sign that the wireless industry and the U.S. television market are set to converge as customers consume more video on their mobile devices.AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)        AT&T; makes bet on video with $48.5 billion DirecTV bidAT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; Inc plans to pay $48.5 billion to buy DirecTV, in the latest sign that the wireless industry and the U.S. television market are set to converge as customers consume more video on their mobile devices.AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       By Asher Levine     SAO PAULO, May 19 Latin American stocks dropped on Monday as a decline in iron ore prices hammered shares of Brazilian miner Vale while America Movil drove losses in Mexico's bourse after AT&T; said it would sell its stake in the Mexican telecommunications firm.     The broader MSCI Latin American stock index  nearly erased the previous session's gains though most of the region's currencies strengthened slightly against the dollar.     Data from China on Sunday shoAT&T; makes bet on video with $48.5 billion DirecTV bidAT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)       AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; Inc plans to pay $48.5 billion to buy DirecTV, in the latest sign that the wireless industry and the U.S. television market are set to converge as customers consume more video on their mobile devices.AT&T; deal opens era of competition with Mexico's SlimAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)      AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     MEXICO CITY, May 19 For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)     US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousAT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)    AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)AT&T; deal opens era of competition with Mexico's SlimUS STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)   US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  MEXICO CITY For a generation, AT&T; and Mexican billionaire Carlos Slim's telephone business stood side by side and grew to become giants of the industry north and south of the Rio Grande.US STOCKS-Wall St advances; Internet stocks lift NasdaqUS STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)  US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close) * Dow up 0.2 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.8 pct   (Updates to late afternoon trading)US STOCKS-Wall St rises; Internet, biotech names lift Nasdaq * Dow up 0.1 pct; S&P; 500 up 0.4 pct; Nasdaq up 0.9 pct   (Updates to close)         
BAX,U.S. justices decline to hear dialysis machine patent case WASHINGTON, May 19 The U.S. Supreme Court declined on Monday to hear an appeal filed by healthcare company Baxter International Inc over a patent dispute with rival Fresenius Medical Care AG & Co. 
BLK,BlackRock advances in pursuit of ETFs with non-daily disclosureUPDATE 1-BlackRock advances in pursuit of ETFs with non-daily disclosure NEW YORK, May 19 BlackRock Inc, the largest U.S. provider of exchange-traded funds, has moved a step further toward launching a new breed of ETFs that would be allowed to keep holdings under wraps for months, instead of the daily disclosure now required.  UPDATE 1-BlackRock advances in pursuit of ETFs with non-daily disclosure NEW YORK, May 19 BlackRock Inc, the largest U.S. provider of exchange-traded funds, has moved a step further toward launching a new breed of ETFs that would be allowed to keep holdings under wraps for months, instead of the daily disclosure now required. NEW YORK, May 19 BlackRock Inc, the largest U.S. provider of exchange-traded funds, has moved a step further in its pursuit of launching a new breed of ETFs that would be allowed to keep their specific holdings under wraps for months at a time, instead of the daily disclosure that is currently required.UPDATE 1-BlackRock advances in pursuit of ETFs with non-daily disclosure NEW YORK, May 19 BlackRock Inc, the largest U.S. provider of exchange-traded funds, has moved a step further toward launching a new breed of ETFs that would be allowed to keep holdings under wraps for months, instead of the daily disclosure now required.  
BA,Exclusive: EU may challenge $8.7 billion U.S. tax breaks in Boeing-Airbus trade dispute - sourcesAirbus chief says A380 to adapt to 777X, attacks U.S. tax breaks BERLIN, May 19 Airbus will keep evolving the design of its A380 superjumbo in response to Boeing's latest jet, the 777X, whose recent launch was bolstered by "unacceptable" Washington state subsidies, the head of the European planemaker said on Monday.  Airbus chief says A380 to adapt to 777X, attacks U.S. tax breaks BERLIN, May 19 Airbus will keep evolving the design of its A380 superjumbo in response to Boeing's latest jet, the 777X, whose recent launch was bolstered by "unacceptable" Washington state subsidies, the head of the European planemaker said on Monday. PARIS The European Union is considering raising the pressure on the United States in the world's largest trade dispute by challenging tax breaks that encouraged planemaker Boeing  to keep production of its latest jet in Washington state, people familiar with the matter said on Friday.Airbus chief says A380 to adapt to 777X, attacks U.S. tax breaks BERLIN, May 19 Airbus will keep evolving the design of its A380 superjumbo in response to Boeing's latest jet, the 777X, whose recent launch was bolstered by "unacceptable" Washington state subsidies, the head of the European planemaker said on Monday.  
CPB,CORRECTED-Campbell Soup posts weaker-than-expected quarterly sales (Corrects paragraph 4 to show net sales rose 0.4 percent, not 1 percent) 
C,M&A; boutiques planting flags in Brazil, challenging large banks SAO PAULO, May 19 Greenhill & Co Inc and other global boutique investment firms are moving into Brazil, aiming to take advantage of strong mergers and acquisitions activity by poaching clients and deals from big-name banks. 
CMCSA,UPDATE 3-'Godzilla' tramples rivals with monster $93 mln debut LOS ANGELES/NEW YORK, May 18 "Godzilla," a remake of the classic Japanese monster movie, crushed its box office competitors over the weekend, devouring $93.2 million in the United States and Canada for the year's second-biggest debut and spawning talk of a sequel. 
FB,France's Publicis wins $500 mln deal with Facebook - Ad Age May 19 France's Publicis Groupe SA has won a digital marketing deal with Facebook Inc worth about $500 million including spending, website Ad Age reported citing an executive familiar with the matter. 
GE,UPDATE 2-Hollande urges govt to seek better Alstom offersHollande urges government to seek better Alstom  offersNY fund manager made insider trading 'jackpot,' SEC tells jurors NEW YORK, May 19 A lawyer for the U.S. Securities and Exchange Commission told jurors Monday a New York fund manager had made a "jackpot" $1.3 million trading on inside information days before a 2001 merger.  NY fund manager made insider trading 'jackpot,' SEC tells jurors NEW YORK, May 19 A lawyer for the U.S. Securities and Exchange Commission told jurors Monday a New York fund manager had made a "jackpot" $1.3 million trading on inside information days before a 2001 merger. PARIS French President Francois Hollande told key ministers on Monday to keep seeking better offers from potential suitors of power and train-making firm Alstom , an official at his office said.NY fund manager made insider trading 'jackpot,' SEC tells jurors NEW YORK, May 19 A lawyer for the U.S. Securities and Exchange Commission told jurors Monday a New York fund manager had made a "jackpot" $1.3 million trading on inside information days before a 2001 merger.   Hollande urges government to seek better Alstom  offersNY fund manager made insider trading 'jackpot,' SEC tells jurors NEW YORK, May 19 A lawyer for the U.S. Securities and Exchange Commission told jurors Monday a New York fund manager had made a "jackpot" $1.3 million trading on inside information days before a 2001 merger.  NY fund manager made insider trading 'jackpot,' SEC tells jurors NEW YORK, May 19 A lawyer for the U.S. Securities and Exchange Commission told jurors Monday a New York fund manager had made a "jackpot" $1.3 million trading on inside information days before a 2001 merger. PARIS French President Francois Hollande told key ministers on Monday to keep seeking better offers from potential suitors of power and train-making firm Alstom , an official at his office said.NY fund manager made insider trading 'jackpot,' SEC tells jurors NEW YORK, May 19 A lawyer for the U.S. Securities and Exchange Commission told jurors Monday a New York fund manager had made a "jackpot" $1.3 million trading on inside information days before a 2001 merger.  PARIS, May 19 French President Francois Hollande told key ministers on Monday to keep seeking better offers from potential suitors of power and train-making firm Alstom , an official at his office said.Hollande urges government to seek better Alstom  offersNY fund manager made insider trading 'jackpot,' SEC tells jurors NEW YORK, May 19 A lawyer for the U.S. Securities and Exchange Commission told jurors Monday a New York fund manager had made a "jackpot" $1.3 million trading on inside information days before a 2001 merger.  NY fund manager made insider trading 'jackpot,' SEC tells jurors NEW YORK, May 19 A lawyer for the U.S. Securities and Exchange Commission told jurors Monday a New York fund manager had made a "jackpot" $1.3 million trading on inside information days before a 2001 merger. PARIS French President Francois Hollande told key ministers on Monday to keep seeking better offers from potential suitors of power and train-making firm Alstom , an official at his office said.NY fund manager made insider trading 'jackpot,' SEC tells jurors NEW YORK, May 19 A lawyer for the U.S. Securities and Exchange Commission told jurors Monday a New York fund manager had made a "jackpot" $1.3 million trading on inside information days before a 2001 merger.   
GM,BRIEF-GM names new senior VP in charge of global CommunicationsGM names new top spokesman, turning to old hand DETROIT, May 19 General Motors Co has turned to an old hand to lead its global communications as it deals with the fallout of defective ignition switches linked to at least 13 deaths and the recall of 2.6 million vehicles.  GM names new top spokesman, turning to old hand DETROIT, May 19 General Motors Co has turned to an old hand to lead its global communications as it deals with the fallout of defective ignition switches linked to at least 13 deaths and the recall of 2.6 million vehicles. DETROIT, May 19 General Motors Co :  * Names Tony Cervone senior vice president of global CommunicationsGM names new top spokesman, turning to old hand DETROIT, May 19 General Motors Co has turned to an old hand to lead its global communications as it deals with the fallout of defective ignition switches linked to at least 13 deaths and the recall of 2.6 million vehicles.  
GS,Deutsche Bank chairman leads battle for the bulge bracket FRANKFURT, May 19 Paul Achleitner, the chairman of Deutsche Bank, believes Europe needs a global investment bank to support the region's companies that can measure up to rivals in the United States. 
JCI,BRIEF-Huayu Auto's unit signs framework agreement with U.S. firm Johnson Controls * Says unit signs framework agreement with Johnson Controls Inc on automotive interior trim business 
JPM,Deutsche Bank chairman leads battle for the bulge bracket FRANKFURT, May 19 Paul Achleitner, the chairman of Deutsche Bank, believes Europe needs a global investment bank to support the region's companies that can measure up to rivals in the United States. 
MUR,Head of Murphy Oil UK steps aside to launch buyout of refinery-sourceUPDATE 1-Statoil shuts production at part of Norway's 4th biggest oilfield OSLO, May 19 Norwegian energy firm Statoil  shut oil production at its Snorre B platform in the North Sea and evacuated a quarter of the personnel there after detecting a soil shift under a drilling template and then oil leak, the company said on Monday.  UPDATE 1-Statoil shuts production at part of Norway's 4th biggest oilfield OSLO, May 19 Norwegian energy firm Statoil  shut oil production at its Snorre B platform in the North Sea and evacuated a quarter of the personnel there after detecting a soil shift under a drilling template and then oil leak, the company said on Monday. LONDON, May 19 The head of Murphy Oil's UK operations Tom McKinlay has taken a leave of absence in order to pursue the acquisition of the company's ailing Milford Haven refinery and retail business, a source close to the company said on Monday.UPDATE 1-Statoil shuts production at part of Norway's 4th biggest oilfield OSLO, May 19 Norwegian energy firm Statoil  shut oil production at its Snorre B platform in the North Sea and evacuated a quarter of the personnel there after detecting a soil shift under a drilling template and then oil leak, the company said on Monday.  
PFE,AstraZeneca tows Britain's FTSE lower after takeover snubAstraZeneca and Deutsche Bank drag down European sharesUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousGLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.        US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousGLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       LONDON, May 19 European equities were pulled down on Monday by the pharmaceuticals group AstraZeneca, which slumped after rejecting a bid from Pfizer, and by Deutsche Bank's announcement of a capital increase.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousGLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.         AstraZeneca and Deutsche Bank drag down European sharesUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousGLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.        US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousGLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       LONDON, May 19 European equities were pulled down on Monday by the pharmaceuticals group AstraZeneca, which slumped after rejecting a bid from Pfizer, and by Deutsche Bank's announcement of a capital increase.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousGLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.        LONDON, May 19 Britain's top shares fell on Monday, dented by a sharp drop in pharmaceutical firm AstraZeneca after it rejected rival Pfizer's higher takeover bid.AstraZeneca and Deutsche Bank drag down European sharesUS STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousGLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.        US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousGLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       LONDON, May 19 European equities were pulled down on Monday by the pharmaceuticals group AstraZeneca, which slumped after rejecting a bid from Pfizer, and by Deutsche Bank's announcement of a capital increase.US STOCKS-S&P; 500 and Nasdaq gain, but investors cautiousGLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.       GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      * Dow off 0.01 pct; S&P; 500 up 0.3 pct; Nasdaq up 0.7 pct   (Updates to midday)GLOBAL MARKETS-Shares trade near break-even as Pfizer deal weighsUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.      UK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     * Dollar tumbles to 3-1/2-month low vs yen as debt yields fallUK takeover rules block higher Pfizer offer before Astra deadlineUK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.     UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    LONDON, May 19 U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.UK takeover rules block higher Pfizer offer before Astra deadlineDeals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.    Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   LONDON U.S. drugmaker Pfizer has left itself no room to return with a higher offer for AstraZeneca before a deadline expires next Monday due to Britain's strict takeover rules, even if the British firm wanted it to, experts say.Deals of the day- Mergers and acquisitionsUPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.   UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  (Adds Telefonica, Publicis, Actis, Murphy Oil, Google; Updates DirecTV, Twitch)UPDATE 12-AstraZeneca rejects Pfizer's take-it-or-leave-it offerPfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.  Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers. * AstraZeneca shares fall 11 pct as hopes of deal dive   (Adds Breakingviews link)Pfizer-AstraZeneca deal not quite dead yet NEW YORK Pfizer Inc may have called its $118 billion bid for AstraZeneca Plc a "final" offer, and its British rival sees no prospect of a deal being revived. But Wall Street isn't ready to call in the undertakers.         
URBN,Urban Outfitters' profit falls 20 percent May 19 Teen apparel retailer Urban Outfitters Inc reported a 20 percent fall in its quarterly profit as costs jumped. 
